These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 11535969

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The effects of diphosphonates on alveolar bone loss.
    Schmidt LJ, Rowe DJ.
    Quintessence Int; 1987 Jul; 18(7):497-501. PubMed ID: 2976952
    [No Abstract] [Full Text] [Related]

  • 43. Bone resorption and turnover in health and disease.
    Mundy GR.
    Bone; 1987 Jul; 8 Suppl 1():S9-16. PubMed ID: 3318891
    [Abstract] [Full Text] [Related]

  • 44. A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism.
    Ammann P, Herter-Clavel C, Lubrano A, Rizzoli R.
    Aging Clin Exp Res; 2003 Dec; 15(6):500-4. PubMed ID: 14959954
    [Abstract] [Full Text] [Related]

  • 45. CLODRONATE: OLD DRUG, NEW USES.
    Saviola G, Abdi-Ali L, Povino MR.
    J Biol Regul Homeost Agents; 2015 Dec; 29(3):719-22. PubMed ID: 26403413
    [Abstract] [Full Text] [Related]

  • 46. Hypocalcaemia after intravenous bisphosphonate: adjuvant bisphosphonate is not currently accepted practice.
    Palmieri C, Dhillon T, Coombes C, Vigushin D.
    BMJ; 2004 Jun 12; 328(7453):1439; author reply 1439-40. PubMed ID: 15191993
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's bone disease.
    Doggrell SA.
    Expert Rev Endocrinol Metab; 2009 Sep 12; 4(5):405-415. PubMed ID: 30736183
    [Abstract] [Full Text] [Related]

  • 49. Bisphosphonates and tumor burden.
    Mundy GR.
    J Clin Oncol; 2002 Aug 01; 20(15):3191-2. PubMed ID: 12149289
    [No Abstract] [Full Text] [Related]

  • 50. Bisphosphonates as adjuvant treatment for breast cancer.
    Gralow JR.
    BMJ; 2002 Nov 09; 325(7372):1051-2. PubMed ID: 12424151
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Clodronate in myelofibrosis: a case report.
    Froom P, Elmalah I, Braester A, Aghai E, Quitt M.
    Am J Med Sci; 2002 Feb 09; 323(2):115-6. PubMed ID: 11863080
    [Abstract] [Full Text] [Related]

  • 53. Zoledronic acid in the treatment of Paget's disease and other benign bone disorders.
    Ringe JD.
    Expert Rev Endocrinol Metab; 2006 Jan 09; 1(1):15-24. PubMed ID: 30743765
    [Abstract] [Full Text] [Related]

  • 54. Pathological fracture of the mandible treated with diphosphonates.
    Califano L, Zupi A, Maremonti P.
    Br J Oral Maxillofac Surg; 1998 Aug 09; 36(4):319. PubMed ID: 9762465
    [No Abstract] [Full Text] [Related]

  • 55. Inhibition of collagenase by a bisphosphonate-group drug in patients with rheumatoid arthritis.
    Valleala H, Teronen O, Friman C, Sorsa T, Solovieva S, Konttinen YT.
    J Rheumatol; 2000 Jun 09; 27(6):1570-2. PubMed ID: 10852301
    [No Abstract] [Full Text] [Related]

  • 56. Minimizing breast cancer's spread.
    Health News; 1998 Sep 10; 4(11):6. PubMed ID: 9745391
    [No Abstract] [Full Text] [Related]

  • 57. Clodronate induced uveitis.
    Fietta P, Manganelli P, Lodigiani L.
    Ann Rheum Dis; 2003 Apr 10; 62(4):378. PubMed ID: 12634250
    [No Abstract] [Full Text] [Related]

  • 58. Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
    Muratore M, Quarta E, Grimaldi A, Calcagnile F, Quarta L.
    Drug Des Devel Ther; 2011 Apr 10; 5():445-54. PubMed ID: 22087064
    [Abstract] [Full Text] [Related]

  • 59. [Use of clodronic acid in mineral metabolism conditions: state of the art in 2000].
    Brandi ML.
    Minerva Med; 2001 Aug 10; 92(4):251-68. PubMed ID: 11535969
    [Abstract] [Full Text] [Related]

  • 60. Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders.
    Ghinoi V, Brandi ML.
    Expert Opin Pharmacother; 2002 Nov 10; 3(11):1643-56. PubMed ID: 12437497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.